Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 984 entries
View as:

Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02972632 Org: User:
Start: 12/22/16 End: 02/06/18 Due: 02/06/19

Effect of Vortioxetine, Paroxetine, and Placebo on Sexual Functioning in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02932904 Org: User:
Start: 11/21/16 End: 06/09/17 Due: 06/09/18

Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00225277 Org: User:
Start: 07/31/03 End: 10/31/07 Due: 10/31/08

Pharmacokinetic and Safety of Ramelteon Between Adolescents With Insomnia and Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00914862 Org: User:
Start: 11/30/09 End: 04/30/11 Due: 04/30/12

Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00763347 Org: User:
Start: 11/30/06 End: 02/28/07 Due: 02/28/08

Clinical and Sociodemographic Characterization of Multiple Myeloma Participants With Symptomatic Relapse and/or Refractory Disease in Spain (CharisMMa Study)

Phase: N/A Priority: Normal
NCT ID: NCT03188536 Org: User:
Start: 07/26/17 End: 01/30/19 Due: 01/30/20

A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT02337725 Org: User:
Start: 02/07/15 End: 09/15/16 Due: 09/15/17

Bioavailability and Pharmacokinetics of Vedolizumab in Healthy Participants Following Single Subcutaneous Administration

Phase: N/A Priority: Normal
NCT ID: NCT02163421 Org: User:
Start: 06/30/14 End: 01/31/15 Due: 01/31/16

Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs

Phase: N/A Priority: Normal
NCT ID: NCT02099708 Org: User:
Start: 10/31/10 End: 03/31/14 Due: 03/31/15

An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02771093 Org: User:
Start: 09/08/16 End: 04/27/17 Due: 04/27/18

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

Phase: N/A Priority: Normal
NCT ID: NCT03650452 Org: User:
Start: 08/08/18 End: 07/20/20 Due: 07/20/21

A Phase 3 Study of Lu AA21004 in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02389816 Org: User:
Start: 04/10/15 End: 03/16/18 Due: 03/16/19

Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01500135 Org: User:
Start: 03/31/12 End: 12/31/15 Due: 12/31/16

Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue

Phase: N/A Priority: Normal
NCT ID: NCT03423173 Org: User:
Start: 02/12/18 End: 01/14/19 Due: 01/14/20

Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT02388724 Org: User:
Start: 03/24/15 End: 07/27/17 Due: 07/27/18

A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04266795 Org: User:
Start: 10/13/20 End: 06/23/25 Due: 06/23/26

Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months

Phase: N/A Priority: Normal
NCT ID: NCT02442752 Org: User:
Start: 06/15/25 End: 12/23/25 Due: 12/23/26

Efficacy and Safety of Ramelteon Combined With Gabapentin in Treating Patients With Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00755508 Org: User:
Start: 11/30/05 End: 09/30/06 Due: 09/30/07

A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT05707351 Org: User:
Start: 03/27/23 End: 09/05/24 Due: 09/05/25

A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02620046 Org: User:
Start: 04/15/16 End: 06/12/24 Due: 06/12/25

An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications

Phase: N/A Priority: Normal
NCT ID: NCT02678676 Org: User:
Start: 11/30/04 End: 11/30/11 Due: 11/30/12

Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT01364649 Org: User:
Start: 06/30/11 End: 12/31/13 Due: 12/31/14

A Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Phase: N/A Priority: Normal
NCT ID: NCT04712110 Org: User:
Start: 02/12/21 End: 03/28/22 Due: 03/28/23

A Study of TAK-071 in People With Parkinson Disease

Phase: N/A Priority: Normal
NCT ID: NCT04334317 Org: User:
Start: 10/21/20 End: 02/27/23 Due: 02/27/24

Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions]

Phase: N/A Priority: Normal
NCT ID: NCT02170207 Org: User:
Start: 01/31/07 End: 03/31/10 Due: 03/31/11